A. Rachel Leheny insider trades
Open-market stock purchases and sales by A. Rachel Leheny, CHIEF EXECUTIVE OFFICER at CalciMedica, Inc, from SEC Form 4 filings since Mar 4, 2010.
Track record: 0% of 17 scored buys are up 5% or more since purchase, averaging -84%.